Jon Snodgres Repligen Corp (RGEN) insider trading activity

Jon Snodgres is Chief Financial Officer of REPLIGEN CORP. Currently has a direct ownership of 37,381 shares of RGEN, which is worth approximately $5.6 Million. The most recent transaction as insider was on May 16, 2023, when has been sold 710 shares (Common Stock) at a price of $154.03 per share, resulting in proceeds of $109,361. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 37.4K

0% 3M change

0% 12M change

Total Value Held $5.6 Million

Jon Snodgres Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 16 2023	SELL Payment of exercise price or tax liability	$109,361 $154.03 p/Share	710 Reduced 1.86%	37,381 Common Stock
Mar 03 2023	SELL Payment of exercise price or tax liability	$690,712 $188.0 p/Share	3,674 Reduced 8.8%	38,091 Common Stock
Mar 03 2023	BUY Grant, award, or other acquisition	-	8,795 Added 17.4%	41,765 Common Stock
Mar 02 2023	BUY Grant, award, or other acquisition	-	4,848 Added 12.82%	32,970 Common Stock
Feb 28 2023	SELL Payment of exercise price or tax liability	$90,278 $173.28 p/Share	521 Reduced 1.82%	28,122 Common Stock
Feb 28 2023	SELL Payment of exercise price or tax liability	$118,286 $173.44 p/Share	682 Reduced 2.33%	28,643 Common Stock
Feb 16 2023	SELL Open market or private sale	$1,129,400 $200.0 p/Share	5,647 Reduced 16.15%	29,325 Common Stock
Oct 07 2022	BUY Exercise of conversion of derivative security	$27,736 $59.52 p/Share	466 Added 1.31%	34,972 Common Stock
Aug 16 2022	SELL Open market or private sale	$1,694,125 $252.93 p/Share	6,698 Reduced 16.26%	34,506 Common Stock
Aug 16 2022	BUY Exercise of conversion of derivative security	$605,924 $150.84 p/Share	4,017 Added 8.88%	41,204 Common Stock
Aug 01 2022	SELL Open market or private sale	$440,000 $220.0 p/Share	2,000 Reduced 5.1%	37,187 Common Stock
May 13 2022	SELL Payment of exercise price or tax liability	$107,085 $150.4 p/Share	712 Reduced 1.78%	39,187 Common Stock
Mar 08 2022	BUY Exercise of conversion of derivative security	$194,552 $46.7 p/Share	4,166 Added 9.45%	39,899 Common Stock
Feb 28 2022	SELL Payment of exercise price or tax liability	$615,474 $196.7 p/Share	3,129 Reduced 8.05%	35,733 Common Stock
Feb 28 2022	BUY Grant, award, or other acquisition	-	5,922 Added 13.42%	38,201 Common Stock
Feb 27 2022	SELL Payment of exercise price or tax liability	$136,706 $196.7 p/Share	695 Reduced 2.07%	32,940 Common Stock
Feb 24 2022	SELL Payment of exercise price or tax liability	$50,897 $189.21 p/Share	269 Reduced 0.79%	33,635 Common Stock
Feb 24 2022	BUY Grant, award, or other acquisition	-	3,443 Added 9.22%	33,904 Common Stock
Feb 17 2022	SELL Payment of exercise price or tax liability	$60,563 $182.42 p/Share	332 Reduced 1.08%	30,461 Common Stock
Feb 17 2022	BUY Grant, award, or other acquisition	-	900 Added 2.84%	30,793 Common Stock
May 14 2021	SELL Open market or private sale	$81,122 $172.6 p/Share	470 Reduced 1.45%	31,893 Common Stock
Mar 04 2021	SELL Open market or private sale	$684,717 $193.15 p/Share	3,545 Reduced 9.87%	32,363 Common Stock
Feb 24 2021	BUY Grant, award, or other acquisition	-	2,410 Added 6.29%	35,908 Common Stock
Jan 25 2021	BUY Exercise of conversion of derivative security	$135,480 $33.87 p/Share	4,000 Added 10.67%	33,498 Common Stock
Jan 04 2021	SELL Open market or private sale	$761,327 $192.4 p/Share	3,957 Reduced 11.83%	29,498 Common Stock

Jon Snodgres

Chief Financial Officer

Waltham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RGEN shares.

Notify only if

Value

Insider Trading

Get notified when an Repligen Corp insider buys or sells RGEN shares.

Notify only if

Operation

Value

Type

News

Receive news related to REPLIGEN CORP

Track Activities on RGEN

Account